178 related articles for article (PubMed ID: 23913163)
1. Inhibition of cell adhesion by a cadherin-11 antibody thwarts bone metastasis.
Lee YC; Bilen MA; Yu G; Lin SC; Huang CF; Ortiz A; Cho H; Song JH; Satcher RL; Kuang J; Gallick GE; Yu-Lee LY; Huang W; Lin SH
Mol Cancer Res; 2013 Nov; 11(11):1401-11. PubMed ID: 23913163
[TBL] [Abstract][Full Text] [Related]
2. Cadherin-11 promotes the metastasis of prostate cancer cells to bone.
Chu K; Cheng CJ; Ye X; Lee YC; Zurita AJ; Chen DT; Yu-Lee LY; Zhang S; Yeh ET; Hu MC; Logothetis CJ; Lin SH
Mol Cancer Res; 2008 Aug; 6(8):1259-67. PubMed ID: 18708358
[TBL] [Abstract][Full Text] [Related]
3. Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis.
Lee YC; Jin JK; Cheng CJ; Huang CF; Song JH; Huang M; Brown WS; Zhang S; Yu-Lee LY; Yeh ET; McIntyre BW; Logothetis CJ; Gallick GE; Lin SH
Mol Cancer Res; 2013 Apr; 11(4):405-17. PubMed ID: 23339185
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance.
Tanaka H; Kono E; Tran CP; Miyazaki H; Yamashiro J; Shimomura T; Fazli L; Wada R; Huang J; Vessella RL; An J; Horvath S; Gleave M; Rettig MB; Wainberg ZA; Reiter RE
Nat Med; 2010 Dec; 16(12):1414-20. PubMed ID: 21057494
[TBL] [Abstract][Full Text] [Related]
5. Cadherin-11 regulates the metastasis of Ewing sarcoma cells to bone.
Hatano M; Matsumoto Y; Fukushi J; Matsunobu T; Endo M; Okada S; Iura K; Kamura S; Fujiwara T; Iida K; Fujiwara Y; Nabeshima A; Yokoyama N; Fukushima S; Oda Y; Iwamoto Y
Clin Exp Metastasis; 2015 Aug; 32(6):579-91. PubMed ID: 26092671
[TBL] [Abstract][Full Text] [Related]
6. GRP78 modulates cell adhesion markers in prostate Cancer and multiple myeloma cell lines.
Cultrara CN; Kozuch SD; Ramasundaram P; Heller CJ; Shah S; Beck AE; Sabatino D; Zilberberg J
BMC Cancer; 2018 Dec; 18(1):1263. PubMed ID: 30563499
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cell-cell adhesion in prostate cancer cells by microRNA-96 through upregulation of E-Cadherin and EpCAM.
Voss G; Haflidadóttir BS; Järemo H; Persson M; Catela Ivkovic T; Wikström P; Ceder Y
Carcinogenesis; 2020 Jul; 41(7):865-874. PubMed ID: 31738404
[TBL] [Abstract][Full Text] [Related]
8. Angiomotin is a novel component of cadherin-11/β-catenin/p120 complex and is critical for cadherin-11-mediated cell migration.
Ortiz A; Lee YC; Yu G; Liu HC; Lin SC; Bilen MA; Cho H; Yu-Lee LY; Lin SH
FASEB J; 2015 Mar; 29(3):1080-91. PubMed ID: 25466890
[TBL] [Abstract][Full Text] [Related]
9. Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts.
Huang CF; Lira C; Chu K; Bilen MA; Lee YC; Ye X; Kim SM; Ortiz A; Wu FL; Logothetis CJ; Yu-Lee LY; Lin SH
Cancer Res; 2010 Jun; 70(11):4580-9. PubMed ID: 20484040
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.
Hall MA; Pinkston KL; Wilganowski N; Robinson H; Ghosh P; Azhdarinia A; Vazquez-Arreguin K; Kolonin AM; Harvey BR; Sevick-Muraca EM
J Nucl Med; 2012 Sep; 53(9):1427-37. PubMed ID: 22872743
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: evidence from in vivo models.
Wang N; Docherty FE; Brown HK; Reeves KJ; Fowles AC; Ottewell PD; Dear TN; Holen I; Croucher PI; Eaton CL
J Bone Miner Res; 2014 Dec; 29(12):2688-96. PubMed ID: 24956445
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin and beta-catenin loss of expression related to bone metastasis in prostate cancer.
Pontes J; Srougi M; Borra PM; Dall' Oglio MF; Ribeiro-Filho LA; Leite KR
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):179-84. PubMed ID: 18685493
[TBL] [Abstract][Full Text] [Related]
13. Neural Cell Adhesion Protein CNTN1 Promotes the Metastatic Progression of Prostate Cancer.
Yan J; Ojo D; Kapoor A; Lin X; Pinthus JH; Aziz T; Bismar TA; Wei F; Wong N; De Melo J; Cutz JC; Major P; Wood G; Peng H; Tang D
Cancer Res; 2016 Mar; 76(6):1603-14. PubMed ID: 26795349
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability.
Corada M; Liao F; Lindgren M; Lampugnani MG; Breviario F; Frank R; Muller WA; Hicklin DJ; Bohlen P; Dejana E
Blood; 2001 Mar; 97(6):1679-84. PubMed ID: 11238107
[TBL] [Abstract][Full Text] [Related]
15. Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.
Putzke AP; Ventura AP; Bailey AM; Akture C; Opoku-Ansah J; Celiktaş M; Hwang MS; Darling DS; Coleman IM; Nelson PS; Nguyen HM; Corey E; Tewari M; Morrissey C; Vessella RL; Knudsen BS
Am J Pathol; 2011 Jul; 179(1):400-10. PubMed ID: 21703419
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
17. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine.
Glinskii OV; Sud S; Mossine VV; Mawhinney TP; Anthony DC; Glinsky GV; Pienta KJ; Glinsky VV
Neoplasia; 2012 Jan; 14(1):65-73. PubMed ID: 22355275
[TBL] [Abstract][Full Text] [Related]
19. CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway.
Chen PC; Cheng HC; Tang CH
Carcinogenesis; 2013 Jul; 34(7):1669-79. PubMed ID: 23536580
[TBL] [Abstract][Full Text] [Related]
20. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.
Li X; Sterling JA; Fan KH; Vessella RL; Shyr Y; Hayward SW; Matrisian LM; Bhowmick NA
Mol Cancer Res; 2012 Apr; 10(4):494-503. PubMed ID: 22290877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
